233 related articles for article (PubMed ID: 2019365)
1. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses.
Duerr RH; Targan SR; Landers CJ; Sutherland LR; Shanahan F
Gastroenterology; 1991 Jun; 100(6):1590-6. PubMed ID: 2019365
[TBL] [Abstract][Full Text] [Related]
2. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ
Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.
Colombel JF; Reumaux D; Duthilleul P; Noël LH; Gower-Rousseau C; Paris JC; Cortot A
Gastroenterol Clin Biol; 1992; 16(8-9):656-60. PubMed ID: 1426820
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
[TBL] [Abstract][Full Text] [Related]
7. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis.
Winter HS; Landers CJ; Winkelstein A; Vidrich A; Targan SR
J Pediatr; 1994 Nov; 125(5 Pt 1):707-11. PubMed ID: 7965422
[TBL] [Abstract][Full Text] [Related]
8. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
9. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.
Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH
Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908
[TBL] [Abstract][Full Text] [Related]
10. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role.
Cambridge G; Rampton DS; Stevens TR; McCarthy DA; Kamm M; Leaker B
Gut; 1992 May; 33(5):668-74. PubMed ID: 1612485
[TBL] [Abstract][Full Text] [Related]
11. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B
Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574
[TBL] [Abstract][Full Text] [Related]
12. Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease.
Proujansky R; Fawcett PT; Gibney KM; Treem WR; Hyams JS
J Pediatr Gastroenterol Nutr; 1993 Aug; 17(2):193-7. PubMed ID: 8229547
[TBL] [Abstract][Full Text] [Related]
13. [A new type of ANCA in sera of patients with ulcerative colitis: effects of therapy and disease severity on serum titer].
Rump JA; Roth M; Schölmerich J; Helfesrieder R; Lüdemann J; Gross WL; Rautmann A; Peter HH
Immun Infekt; 1992 Feb; 20(1):16-8. PubMed ID: 1563754
[TBL] [Abstract][Full Text] [Related]
14. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.
Granito A; Zauli D; Muratori P; Muratori L; Grassi A; Bortolotti R; Petrolini N; Veronesi L; Gionchetti P; Bianchi FB; Volta U
Aliment Pharmacol Ther; 2005 Apr; 21(7):881-7. PubMed ID: 15801923
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to molecular targets in neutrophils in patients with ulcerative colitis.
Brimnes J; Nielsen OH; Wiik A; Heegaard NH
Dig Dis Sci; 1999 Feb; 44(2):415-23. PubMed ID: 10063932
[TBL] [Abstract][Full Text] [Related]
17. p-ANCA of undefined specificity in ulcerative colitis: correlation to disease activity and therapy.
Rump JA; Wörner I; Roth M; Schölmerich J; Hänsch M; Peter HH
Adv Exp Med Biol; 1993; 336():507-13. PubMed ID: 8296665
[TBL] [Abstract][Full Text] [Related]
18. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease.
Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL
Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
Lo SK; Fleming KA; Chapman RW
Gut; 1992 Oct; 33(10):1370-5. PubMed ID: 1446862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
